Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Management tracks

July 15, 2017 1:11 AM UTC

Immunotherapy company Advaxis Inc. (NASDAQ:ADXS) said President and CEO Daniel O’Connor resigned. CBO Anthony Lombardo will be interim CEO while the company seeks a replacement.

Rare disease company OxThera AB (Stockholm, Sweden) named Matthew Gantz CEO. He succeeds Elisabeth Lindner, who will be the company's COO. Gantz was EVP at the U.S. division of BTG plc (LSE:BTG)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article